Table 3 The Relationship between Therapeutic Agents and Platelet Recovery Following Nadir in E. coli
RNA Fragments | Dose | Chemotherapy | Patient Number | Median Platelet Counts | Range | Kruskall Wallis |
|---|---|---|---|---|---|---|
E. coli | 60 | Non mito, non Platinum | 11 | 163 | 90 to 257 | 0.09 |
Carboplatin | 2 | 122.5 | 118 to 127 | |||
Cisplatin | 2 | 95 | 62 to 129 | |||
Mitomycin C | 1 | 62 | 62 | |||
E. coli | 80 | Non mito, non Platinum | 10 | 137.5 | 83 to 210 | 0.3 |
Carboplatin | 2 | 156 | 110 to 202 | |||
Cisplatin | 1 | 173 | 173 | |||
Mitomycin C | 2 | 168 | 149 to 187 |